课题基金 / 基金详情

SUrgical and Pharmacological novel intERventions to Improve Overall Results of Saphenous Vein Graft patency in coronary artery bypass grafting surgery. The "SUPERIOR SVG" Study: An International Multi-centred Randomized Controlled Clinical Trial

SUrgical and Pharmacological novel intERventions to Improve Overall Results of Saphenous Vein Graft patency in coronary artery bypass grafting surgery. The "SUPERIOR SVG" Study: An International Multi-centred Randomized Controlled Clinical Trial
手术和药理学新干预措施可改善冠状动脉旁路移植手术中隐静脉移植物通畅的总体结果。
批准号：
247812
负责人：
Deb Saswata
金额：
$10.93万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-11-01 至 2014-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=247812&lang=en
关键词：
Coronary Artery Bypass Grafting Double Blinded Fish Oil Graft Patency International Multi-Centered No-Touch Vein Harvesting Placebo Randomized Clinical Trial Saphenous Vein Graft

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
背景：冠状动脉阻塞引起的缺血性心脏病（IHD）是世界上主要的死亡原因。冠状动脉搭桥手术（CABG）改善了广泛冠状动脉阻塞患者的生存率和症状; 2008年，近15
英文摘要
Background: Ischemic heart disease (IHD) due to coronary artery blockages is the leading cause of death in the world. Coronary artery bypass surgery (CABG) improves survival and symptoms in patients with extensive coronary obstructions; in 2008, almost 15
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金